Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merit Medical Systems (MMSI) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Merit Medical Systems (MMSI) over the last 16 years, with Q3 2025 value amounting to $27.7 million.

  • Merit Medical Systems' Net Income towards Common Stockholders fell 247.5% to $27.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.5 million, marking a year-over-year decrease of 359.05%. This contributed to the annual value of $105.5 million for FY2024, which is 2900.4% up from last year.
  • Per Merit Medical Systems' latest filing, its Net Income towards Common Stockholders stood at $27.7 million for Q3 2025, which was down 247.5% from $32.6 million recorded in Q2 2025.
  • Merit Medical Systems' 5-year Net Income towards Common Stockholders high stood at $35.7 million for Q2 2024, and its period low was $4.9 million during Q2 2021.
  • For the 5-year period, Merit Medical Systems' Net Income towards Common Stockholders averaged around $20.1 million, with its median value being $18.5 million (2022).
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first surged by 54322.15% in 2021, then crashed by 1907.33% in 2023.
  • Merit Medical Systems' Net Income towards Common Stockholders (Quarter) stood at $16.0 million in 2021, then rose by 15.83% to $18.5 million in 2022, then dropped by 19.07% to $15.0 million in 2023, then dropped by 12.76% to $13.1 million in 2024, then soared by 112.18% to $27.7 million in 2025.
  • Its Net Income towards Common Stockholders stands at $27.7 million for Q3 2025, versus $32.6 million for Q2 2025 and $30.1 million for Q1 2025.